These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 20600871)

  • 1. The role of antibodies in multiple sclerosis.
    Weber MS; Hemmer B; Cepok S
    Biochim Biophys Acta; 2011 Feb; 1812(2):239-45. PubMed ID: 20600871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epitopes on myelin proteins recognized by autoantibodies present in multiple sclerosis patients].
    Jaśkiewicz E
    Postepy Hig Med Dosw (Online); 2004; 58():472-82. PubMed ID: 15765008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
    Lee DH; Linker RA
    Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MS and the B cell controversy.
    Cross AH; Waubant E
    Biochim Biophys Acta; 2011 Feb; 1812(2):231-8. PubMed ID: 20674743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response.
    Hundgeburth LC; Wunsch M; Rovituso D; Recks MS; Addicks K; Lehmann PV; Kuerten S
    Clin Immunol; 2013 Mar; 146(3):155-64. PubMed ID: 23352967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).
    Ziemssen T; Ziemssen F
    Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cells and antibodies in CNS demyelinating disease.
    Cross AH; Trotter JL; Lyons J
    J Neuroimmunol; 2001 Jan; 112(1-2):1-14. PubMed ID: 11108928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multiple sclerosis and experimental autoimmune encephalomyelitis].
    Béraud-Juven E
    Rev Prat; 1994 Jan; 44(1):69-74. PubMed ID: 8178062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells?
    Agahozo MC; Peferoen L; Baker D; Amor S
    Mult Scler Relat Disord; 2016 Sep; 9():110-7. PubMed ID: 27645355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
    Cross AH; Stark JL
    Immunol Res; 2005; 32(1-3):85-97. PubMed ID: 16106061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.
    Chen D; Ireland SJ; Davis LS; Kong X; Stowe AM; Wang Y; White WI; Herbst R; Monson NL
    J Immunol; 2016 Feb; 196(4):1541-9. PubMed ID: 26764035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
    Batoulis H; Addicks K; Kuerten S
    Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell depletion abrogates T cell-mediated demyelination in an antibody-nondependent common marmoset experimental autoimmune encephalomyelitis model.
    Jagessar SA; Heijmans N; Bauer J; Blezer EL; Laman JD; Hellings N; 't Hart BA
    J Neuropathol Exp Neurol; 2012 Aug; 71(8):716-28. PubMed ID: 22805775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis].
    Rodríguez-Rodríguez Y; Suárez-Luis I
    Rev Neurol; 2003 Apr 1-15; 36(7):649-52. PubMed ID: 12666047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.
    Martin R; McFarland HF
    Crit Rev Clin Lab Sci; 1995; 32(2):121-82. PubMed ID: 7598789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants.
    Blauth K; Soltys J; Matschulat A; Reiter CR; Ritchie A; Baird NL; Bennett JL; Owens GP
    Acta Neuropathol; 2015 Dec; 130(6):765-81. PubMed ID: 26511623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological basis for the development of tissue inflammation and organ-specific autoimmunity in animal models of multiple sclerosis.
    Korn T; Mitsdoerffer M; Kuchroo VK
    Results Probl Cell Differ; 2010; 51():43-74. PubMed ID: 19513635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cells in multiple sclerosis.
    Wekerle H
    Autoimmunity; 2017 Feb; 50(1):57-60. PubMed ID: 28166681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cells in spontaneous autoimmune diseases of the central nervous system.
    Berer K; Wekerle H; Krishnamoorthy G
    Mol Immunol; 2011 Jun; 48(11):1332-7. PubMed ID: 21146219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.